Cover Image

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways

Nonalcoholic fatty liver disease (NAFLD), manifested as the aberrant accumulation of lipids in hepatocytes and inflammation, has become an important cause of advanced liver diseases and hepatic malignancies worldwide. However, no effective therapy has been approved yet. Aurantio-obtusin (AO) is a ma...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fei Zhou (Author), Mingning Ding (Author), Yiqing Gu (Author), Guifang Fan (Author), Chuanyang Liu (Author), Yijie Li (Author), Rong Sun (Author), Jianzhi Wu (Author), Jianchao Li (Author), Xiaoyong Xue (Author), Hongjuan Li (Author), Xiaojiaoyang Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Urine Metabolomics Study on Potential Hepatoxic Biomarkers Identification in Rats Induced by Aurantio-Obtusin
by: Longlong Xu, et al.
Published: (2020)

Aurantio-obtusin relaxes systemic arteries through endothelial PI3K/AKT/eNOS-dependent signaling pathway in rats
by: Shuzhen Li, et al.
Published: (2015)

Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation
by: Jianzhi Wu, et al.
Published: (2021)

Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK
by: Ying Yang, et al.
Published: (2021)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
by: Xiaojiaoyang Li, et al.
Published: (2021)

Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
by: Xiaoyong Xue, et al.
Published: (2021)

Curcumin Induces Autophagy via Activating the AMPK Signaling Pathway in Lung Adenocarcinoma Cells
by: Kui Xiao, et al.
Published: (2013)

Protective effect of omega-3 polyunsaturated fatty acids on sepsis via the AMPK/mTOR pathway
by: Peng Liu, et al.
Published: (2023)

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice
by: Xiaoyong Xue, et al.
Published: (2024)

Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity
by: Yudi Zhang, et al.
Published: (2021)

Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy
by: Li Zhang, et al.
Published: (2018)

Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway
by: Daewon Han, et al.
Published: (2023)

Salvia chinensia Benth induces autophagy in esophageal cancer cells via AMPK/ULK1 signaling pathway
by: Lei Jia, et al.
Published: (2022)

Radix Polygoni Multiflori and Its Main Component Emodin Attenuate Non-Alcoholic Fatty Liver Disease in Zebrafish by Regulation of AMPK Signaling Pathway
by: Yu L, et al.
Published: (2020)

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
by: Yuting Ma, et al.
Published: (2022)

Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
by: Jianzhi Wu, et al.
Published: (2020)

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
by: Ting Li, et al.
Published: (2021)

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
by: Ruifeng Tian, et al.
Published: (2023)

High levels of fatty acid-binding protein 5 excessively enhances fatty acid synthesis and proliferation of granulosa cells in polycystic ovary syndrome
by: Jingyu Liu, et al.
Published: (2024)

Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
by: Liuran Li, et al.
Published: (2021)

Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism
by: Bin Li, et al.
Published: (2024)

Medication rule and mechanism of traditional Chinese medicine in treating metabolism-associated fatty liver disease based on bioinformatics technology
by: Zhang Yunkun, et al.
Published: (2023)

Polymorphisms of Fatty Acid Elongase 2 Gene Afftects Risk of Pulmonary Tuberculosis in China Han Population
by: Min Mu, et al.
Published: (2021)

Berberine Reduces Lipid Accumulation by Promoting Fatty Acid Oxidation in Renal Tubular Epithelial Cells of the Diabetic Kidney
by: Qingfeng Rong, et al.
Published: (2022)

Activation of CTHRC1 by HOXB9 promotes angiogenesis through fatty acid metabolism in lung adenocarcinoma
by: Keqi Liu, et al.
Published: (2023)

Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism
by: Linjie Pan, et al.
Published: (2024)

Sodium Selenite Induces Autophagy and Apoptosis in Cervical Cancer Cells via Mitochondrial ROS-Activated AMPK/mTOR/FOXO3a Pathway
by: Cunqi Lv, et al.
Published: (2024)

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
by: Tingli Guo, et al.
Published: (2023)

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
by: Runping Liu, et al.
Published: (2024)

Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway
by: Shu-xian Li, et al.
Published: (2021)

A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study
by: Yang Zhou, et al.
Published: (2022)

Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation
by: Pan Li, et al.
Published: (2022)

Atractyloside Protect Mice Against Liver Steatosis by Activation of Autophagy via ANT-AMPK-mTORC1 Signaling Pathway
by: Pengfei Zhang, et al.
Published: (2021)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy
by: Zhang X, et al.
Published: (2020)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
by: Siyu Yu, et al.
Published: (2021)

Mesenchymal stromal cells ameliorate diabetes‐induced muscle atrophy through exosomes by enhancing AMPK/ULK1‐mediated autophagy
by: Jia Song, et al.
Published: (2023)

Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway
by: He H, et al.
Published: (2023)

Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK
by: Jozaa Z. ALTamimi, et al.
Published: (2022)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]
by: Zhang X, et al.
Published: (2021)

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease
by: Meina Zou, et al.
Published: (2021)